{"entity":{"type":"insider","cik":"0001602744","url":"/insider/0001602744","json_url":"/insider/0001602744.json","name":"Presidio Management Group X LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":80,"n_filings":16,"first":"2020-05-27","last":"2022-08-03","span_basis":"filed_date"},"name_variants":[{"name":"Presidio Management Group X LLC","source":"filing","n_filings":16,"first_seen":"2020-05-27","last_seen":"2022-08-03"}],"transactions":[{"id":6208479,"accession":"0001062993-22-017215","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001062993-22-017215","line_url":"/filing/0001062993-22-017215#line-6","is_derivative":false,"issuer_cik":"0001225480","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001225480","owner_cik":null,"owner_name":"US VENTURE PARTNERS X LP; Tansey Casey M; ROOT JONATHAN D; Presidio Management Group X LLC; USVP X AFFILIATES LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":57580.0,"shares_display":"57,580","price_per_share":0.804,"price_display":"0.80","price_state":"stated","total_value":46294.32,"total_display":"46,294.32","shares_owned_after":3981940.0,"shares_owned_after_display":"3,981,940","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-08-03","filed_date":"2022-08-03","scope":"insider"},{"id":6208475,"accession":"0001062993-22-017215","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001062993-22-017215","line_url":"/filing/0001062993-22-017215#line-5","is_derivative":false,"issuer_cik":"0001225480","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001225480","owner_cik":null,"owner_name":"US VENTURE PARTNERS X LP; Tansey Casey M; ROOT JONATHAN D; Presidio Management Group X LLC; USVP X AFFILIATES LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1796.0,"shares_display":"1,796","price_per_share":0.804,"price_display":"0.80","price_state":"stated","total_value":1443.984,"total_display":"1,443.98","shares_owned_after":127569.0,"shares_owned_after_display":"127,569","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-08-03","filed_date":"2022-08-03","scope":"insider"},{"id":6208470,"accession":"0001062993-22-017215","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001062993-22-017215","line_url":"/filing/0001062993-22-017215#line-4","is_derivative":false,"issuer_cik":"0001225480","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001225480","owner_cik":null,"owner_name":"US VENTURE PARTNERS X LP; Tansey Casey M; ROOT JONATHAN D; Presidio Management Group X LLC; USVP X AFFILIATES LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27348.0,"shares_display":"27,348","price_per_share":0.797,"price_display":"0.80","price_state":"stated","total_value":21796.356,"total_display":"21,796.36","shares_owned_after":4039520.0,"shares_owned_after_display":"4,039,520","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-08-02","filed_date":"2022-08-03","scope":"insider"},{"id":6208466,"accession":"0001062993-22-017215","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001062993-22-017215","line_url":"/filing/0001062993-22-017215#line-3","is_derivative":false,"issuer_cik":"0001225480","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001225480","owner_cik":null,"owner_name":"US VENTURE PARTNERS X LP; Tansey Casey M; ROOT JONATHAN D; Presidio Management Group X LLC; USVP X AFFILIATES LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":853.0,"shares_display":"853","price_per_share":0.797,"price_display":"0.80","price_state":"stated","total_value":679.841,"total_display":"679.84","shares_owned_after":129365.0,"shares_owned_after_display":"129,365","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-08-02","filed_date":"2022-08-03","scope":"insider"},{"id":6208463,"accession":"0001062993-22-017215","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-22-017215","line_url":"/filing/0001062993-22-017215#line-2","is_derivative":false,"issuer_cik":"0001225480","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001225480","owner_cik":null,"owner_name":"US VENTURE PARTNERS X LP; Tansey Casey M; ROOT JONATHAN D; Presidio Management Group X LLC; USVP X AFFILIATES LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25896.0,"shares_display":"25,896","price_per_share":0.786,"price_display":"0.79","price_state":"stated","total_value":20354.256,"total_display":"20,354.26","shares_owned_after":4066868.0,"shares_owned_after_display":"4,066,868","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-08-01","filed_date":"2022-08-03","scope":"insider"},{"id":6208460,"accession":"0001062993-22-017215","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-22-017215","line_url":"/filing/0001062993-22-017215#line-1","is_derivative":false,"issuer_cik":"0001225480","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001225480","owner_cik":null,"owner_name":"US VENTURE PARTNERS X LP; Tansey Casey M; ROOT JONATHAN D; Presidio Management Group X LLC; USVP X AFFILIATES LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":807.0,"shares_display":"807","price_per_share":0.786,"price_display":"0.79","price_state":"stated","total_value":634.302,"total_display":"634.30","shares_owned_after":130218.0,"shares_owned_after_display":"130,218","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-08-01","filed_date":"2022-08-03","scope":"insider"},{"id":6350310,"accession":"0001062993-22-016924","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-22-016924","line_url":"/filing/0001062993-22-016924#line-2","is_derivative":false,"issuer_cik":"0001225480","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001225480","owner_cik":null,"owner_name":"Presidio Management Group X LLC; ROOT JONATHAN D; US VENTURE PARTNERS X LP; Tansey Casey M; USVP X AFFILIATES LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31533.0,"shares_display":"31,533","price_per_share":0.892,"price_display":"0.89","price_state":"stated","total_value":28127.436,"total_display":"28,127.44","shares_owned_after":4092764.0,"shares_owned_after_display":"4,092,764","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-07-28","filed_date":"2022-07-29","scope":"insider"},{"id":6350307,"accession":"0001062993-22-016924","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-22-016924","line_url":"/filing/0001062993-22-016924#line-1","is_derivative":false,"issuer_cik":"0001225480","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001225480","owner_cik":null,"owner_name":"Presidio Management Group X LLC; ROOT JONATHAN D; US VENTURE PARTNERS X LP; Tansey Casey M; USVP X AFFILIATES LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":984.0,"shares_display":"984","price_per_share":0.892,"price_display":"0.89","price_state":"stated","total_value":877.728,"total_display":"877.73","shares_owned_after":131025.0,"shares_owned_after_display":"131,025","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-07-28","filed_date":"2022-07-29","scope":"insider"},{"id":6984176,"accession":"0001062993-22-016802","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001062993-22-016802","line_url":"/filing/0001062993-22-016802#line-6","is_derivative":false,"issuer_cik":"0001225480","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001225480","owner_cik":null,"owner_name":"US VENTURE PARTNERS X LP; Tansey Casey M; Presidio Management Group X LLC; ROOT JONATHAN D; USVP X AFFILIATES LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":42344.0,"shares_display":"42,344","price_per_share":0.892,"price_display":"0.89","price_state":"stated","total_value":37770.848,"total_display":"37,770.85","shares_owned_after":4124297.0,"shares_owned_after_display":"4,124,297","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-07-27","filed_date":"2022-07-27","scope":"insider"},{"id":6984172,"accession":"0001062993-22-016802","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001062993-22-016802","line_url":"/filing/0001062993-22-016802#line-5","is_derivative":false,"issuer_cik":"0001225480","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001225480","owner_cik":null,"owner_name":"US VENTURE PARTNERS X LP; Tansey Casey M; Presidio Management Group X LLC; ROOT JONATHAN D; USVP X AFFILIATES LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1321.0,"shares_display":"1,321","price_per_share":0.892,"price_display":"0.89","price_state":"stated","total_value":1178.332,"total_display":"1,178.33","shares_owned_after":132009.0,"shares_owned_after_display":"132,009","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-07-27","filed_date":"2022-07-27","scope":"insider"},{"id":6984170,"accession":"0001062993-22-016802","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001062993-22-016802","line_url":"/filing/0001062993-22-016802#line-4","is_derivative":false,"issuer_cik":"0001225480","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001225480","owner_cik":null,"owner_name":"US VENTURE PARTNERS X LP; Tansey Casey M; Presidio Management Group X LLC; ROOT JONATHAN D; USVP X AFFILIATES LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2691.0,"shares_display":"2,691","price_per_share":0.904,"price_display":"0.90","price_state":"stated","total_value":2432.664,"total_display":"2,432.66","shares_owned_after":4166641.0,"shares_owned_after_display":"4,166,641","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-07-26","filed_date":"2022-07-27","scope":"insider"},{"id":6984167,"accession":"0001062993-22-016802","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001062993-22-016802","line_url":"/filing/0001062993-22-016802#line-3","is_derivative":false,"issuer_cik":"0001225480","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001225480","owner_cik":null,"owner_name":"US VENTURE PARTNERS X LP; Tansey Casey M; Presidio Management Group X LLC; ROOT JONATHAN D; USVP X AFFILIATES LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":84.0,"shares_display":"84","price_per_share":0.904,"price_display":"0.90","price_state":"stated","total_value":75.936,"total_display":"75.94","shares_owned_after":133330.0,"shares_owned_after_display":"133,330","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-07-26","filed_date":"2022-07-27","scope":"insider"},{"id":6984164,"accession":"0001062993-22-016802","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-22-016802","line_url":"/filing/0001062993-22-016802#line-2","is_derivative":false,"issuer_cik":"0001225480","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001225480","owner_cik":null,"owner_name":"US VENTURE PARTNERS X LP; Tansey Casey M; Presidio Management Group X LLC; ROOT JONATHAN D; USVP X AFFILIATES LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2210.0,"shares_display":"2,210","price_per_share":0.931,"price_display":"0.93","price_state":"stated","total_value":2057.51,"total_display":"2,057.51","shares_owned_after":4169332.0,"shares_owned_after_display":"4,169,332","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-07-25","filed_date":"2022-07-27","scope":"insider"},{"id":6984161,"accession":"0001062993-22-016802","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-22-016802","line_url":"/filing/0001062993-22-016802#line-1","is_derivative":false,"issuer_cik":"0001225480","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001225480","owner_cik":null,"owner_name":"US VENTURE PARTNERS X LP; Tansey Casey M; Presidio Management Group X LLC; ROOT JONATHAN D; USVP X AFFILIATES LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":69.0,"shares_display":"69","price_per_share":0.931,"price_display":"0.93","price_state":"stated","total_value":64.239,"total_display":"64.24","shares_owned_after":133414.0,"shares_owned_after_display":"133,414","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-07-25","filed_date":"2022-07-27","scope":"insider"},{"id":6676403,"accession":"0001062993-22-016678","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001062993-22-016678","line_url":"/filing/0001062993-22-016678#line-6","is_derivative":false,"issuer_cik":"0001225480","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001225480","owner_cik":null,"owner_name":"US VENTURE PARTNERS X LP; Presidio Management Group X LLC; USVP X AFFILIATES LP; ROOT JONATHAN D; Tansey Casey M","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7383.0,"shares_display":"7,383","price_per_share":0.91,"price_display":"0.91","price_state":"stated","total_value":6718.53,"total_display":"6,718.53","shares_owned_after":4171542.0,"shares_owned_after_display":"4,171,542","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-07-22","filed_date":"2022-07-22","scope":"insider"},{"id":6676396,"accession":"0001062993-22-016678","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001062993-22-016678","line_url":"/filing/0001062993-22-016678#line-5","is_derivative":false,"issuer_cik":"0001225480","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001225480","owner_cik":null,"owner_name":"US VENTURE PARTNERS X LP; Presidio Management Group X LLC; USVP X AFFILIATES LP; ROOT JONATHAN D; Tansey Casey M","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":231.0,"shares_display":"231","price_per_share":0.911,"price_display":"0.91","price_state":"stated","total_value":210.441,"total_display":"210.44","shares_owned_after":133483.0,"shares_owned_after_display":"133,483","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-07-22","filed_date":"2022-07-22","scope":"insider"},{"id":6676393,"accession":"0001062993-22-016678","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001062993-22-016678","line_url":"/filing/0001062993-22-016678#line-4","is_derivative":false,"issuer_cik":"0001225480","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001225480","owner_cik":null,"owner_name":"US VENTURE PARTNERS X LP; Presidio Management Group X LLC; USVP X AFFILIATES LP; ROOT JONATHAN D; Tansey Casey M","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2584.0,"shares_display":"2,584","price_per_share":0.955,"price_display":"0.96","price_state":"stated","total_value":2467.72,"total_display":"2,467.72","shares_owned_after":4178925.0,"shares_owned_after_display":"4,178,925","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-07-21","filed_date":"2022-07-22","scope":"insider"},{"id":6676387,"accession":"0001062993-22-016678","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001062993-22-016678","line_url":"/filing/0001062993-22-016678#line-3","is_derivative":false,"issuer_cik":"0001225480","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001225480","owner_cik":null,"owner_name":"US VENTURE PARTNERS X LP; Presidio Management Group X LLC; USVP X AFFILIATES LP; ROOT JONATHAN D; Tansey Casey M","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":81.0,"shares_display":"81","price_per_share":0.956,"price_display":"0.96","price_state":"stated","total_value":77.436,"total_display":"77.44","shares_owned_after":133714.0,"shares_owned_after_display":"133,714","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-07-21","filed_date":"2022-07-22","scope":"insider"},{"id":6676385,"accession":"0001062993-22-016678","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-22-016678","line_url":"/filing/0001062993-22-016678#line-2","is_derivative":false,"issuer_cik":"0001225480","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001225480","owner_cik":null,"owner_name":"US VENTURE PARTNERS X LP; Presidio Management Group X LLC; USVP X AFFILIATES LP; ROOT JONATHAN D; Tansey Casey M","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9726.0,"shares_display":"9,726","price_per_share":1.001,"price_display":"1.00","price_state":"stated","total_value":9735.726,"total_display":"9,735.73","shares_owned_after":4181509.0,"shares_owned_after_display":"4,181,509","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-07-20","filed_date":"2022-07-22","scope":"insider"},{"id":6676381,"accession":"0001062993-22-016678","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-22-016678","line_url":"/filing/0001062993-22-016678#line-1","is_derivative":false,"issuer_cik":"0001225480","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001225480","owner_cik":null,"owner_name":"US VENTURE PARTNERS X LP; Presidio Management Group X LLC; USVP X AFFILIATES LP; ROOT JONATHAN D; Tansey Casey M","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":304.0,"shares_display":"304","price_per_share":1.001,"price_display":"1.00","price_state":"stated","total_value":304.304,"total_display":"304.30","shares_owned_after":133795.0,"shares_owned_after_display":"133,795","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-07-20","filed_date":"2022-07-22","scope":"insider"},{"id":6365696,"accession":"0001062993-22-016514","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001062993-22-016514","line_url":"/filing/0001062993-22-016514#line-6","is_derivative":false,"issuer_cik":"0001225480","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001225480","owner_cik":null,"owner_name":"USVP X AFFILIATES LP; ROOT JONATHAN D; Presidio Management Group X LLC; US VENTURE PARTNERS X LP; Tansey Casey M","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2670.0,"shares_display":"2,670","price_per_share":1.0,"price_display":"1.00","price_state":"stated","total_value":2670.0,"total_display":"2,670.00","shares_owned_after":4191235.0,"shares_owned_after_display":"4,191,235","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-07-19","filed_date":"2022-07-19","scope":"insider"},{"id":6365695,"accession":"0001062993-22-016514","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001062993-22-016514","line_url":"/filing/0001062993-22-016514#line-5","is_derivative":false,"issuer_cik":"0001225480","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001225480","owner_cik":null,"owner_name":"USVP X AFFILIATES LP; ROOT JONATHAN D; Presidio Management Group X LLC; US VENTURE PARTNERS X LP; Tansey Casey M","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":84.0,"shares_display":"84","price_per_share":1.0,"price_display":"1.00","price_state":"stated","total_value":84.0,"total_display":"84.00","shares_owned_after":134099.0,"shares_owned_after_display":"134,099","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-07-19","filed_date":"2022-07-19","scope":"insider"},{"id":6365694,"accession":"0001062993-22-016514","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001062993-22-016514","line_url":"/filing/0001062993-22-016514#line-4","is_derivative":false,"issuer_cik":"0001225480","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001225480","owner_cik":null,"owner_name":"USVP X AFFILIATES LP; ROOT JONATHAN D; Presidio Management Group X LLC; US VENTURE PARTNERS X LP; Tansey Casey M","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20352.0,"shares_display":"20,352","price_per_share":1.08,"price_display":"1.08","price_state":"stated","total_value":21980.16,"total_display":"21,980.16","shares_owned_after":4193905.0,"shares_owned_after_display":"4,193,905","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-07-18","filed_date":"2022-07-19","scope":"insider"},{"id":6365693,"accession":"0001062993-22-016514","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001062993-22-016514","line_url":"/filing/0001062993-22-016514#line-3","is_derivative":false,"issuer_cik":"0001225480","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001225480","owner_cik":null,"owner_name":"USVP X AFFILIATES LP; ROOT JONATHAN D; Presidio Management Group X LLC; US VENTURE PARTNERS X LP; Tansey Casey M","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":635.0,"shares_display":"635","price_per_share":1.081,"price_display":"1.08","price_state":"stated","total_value":686.435,"total_display":"686.44","shares_owned_after":134183.0,"shares_owned_after_display":"134,183","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-07-18","filed_date":"2022-07-19","scope":"insider"},{"id":6365692,"accession":"0001062993-22-016514","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-22-016514","line_url":"/filing/0001062993-22-016514#line-2","is_derivative":false,"issuer_cik":"0001225480","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001225480","owner_cik":null,"owner_name":"USVP X AFFILIATES LP; ROOT JONATHAN D; Presidio Management Group X LLC; US VENTURE PARTNERS X LP; Tansey Casey M","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":44477.0,"shares_display":"44,477","price_per_share":1.108,"price_display":"1.11","price_state":"stated","total_value":49280.516,"total_display":"49,280.52","shares_owned_after":4214257.0,"shares_owned_after_display":"4,214,257","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-07-15","filed_date":"2022-07-19","scope":"insider"},{"id":6365691,"accession":"0001062993-22-016514","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-22-016514","line_url":"/filing/0001062993-22-016514#line-1","is_derivative":false,"issuer_cik":"0001225480","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001225480","owner_cik":null,"owner_name":"USVP X AFFILIATES LP; ROOT JONATHAN D; Presidio Management Group X LLC; US VENTURE PARTNERS X LP; Tansey Casey M","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1423.0,"shares_display":"1,423","price_per_share":1.108,"price_display":"1.11","price_state":"stated","total_value":1576.684,"total_display":"1,576.68","shares_owned_after":134818.0,"shares_owned_after_display":"134,818","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-07-15","filed_date":"2022-07-19","scope":"insider"},{"id":6208218,"accession":"0001062993-22-013050","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001062993-22-013050","line_url":"/filing/0001062993-22-013050#line-6","is_derivative":false,"issuer_cik":"0001225480","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001225480","owner_cik":null,"owner_name":"Tansey Casey M; Presidio Management Group X LLC; US VENTURE PARTNERS X LP; USVP X AFFILIATES LP; ROOT JONATHAN D","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8308.0,"shares_display":"8,308","price_per_share":1.69,"price_display":"1.69","price_state":"stated","total_value":14040.52,"total_display":"14,040.52","shares_owned_after":4258734.0,"shares_owned_after_display":"4,258,734","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-19","filed_date":"2022-05-19","scope":"insider"},{"id":6208214,"accession":"0001062993-22-013050","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001062993-22-013050","line_url":"/filing/0001062993-22-013050#line-5","is_derivative":false,"issuer_cik":"0001225480","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001225480","owner_cik":null,"owner_name":"Tansey Casey M; Presidio Management Group X LLC; US VENTURE PARTNERS X LP; USVP X AFFILIATES LP; ROOT JONATHAN D","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":266.0,"shares_display":"266","price_per_share":1.689,"price_display":"1.69","price_state":"stated","total_value":449.274,"total_display":"449.27","shares_owned_after":136241.0,"shares_owned_after_display":"136,241","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-19","filed_date":"2022-05-19","scope":"insider"},{"id":6208210,"accession":"0001062993-22-013050","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001062993-22-013050","line_url":"/filing/0001062993-22-013050#line-4","is_derivative":false,"issuer_cik":"0001225480","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001225480","owner_cik":null,"owner_name":"Tansey Casey M; Presidio Management Group X LLC; US VENTURE PARTNERS X LP; USVP X AFFILIATES LP; ROOT JONATHAN D","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13649.0,"shares_display":"13,649","price_per_share":1.734,"price_display":"1.73","price_state":"stated","total_value":23667.366,"total_display":"23,667.37","shares_owned_after":4267042.0,"shares_owned_after_display":"4,267,042","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-18","filed_date":"2022-05-19","scope":"insider"},{"id":6208207,"accession":"0001062993-22-013050","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001062993-22-013050","line_url":"/filing/0001062993-22-013050#line-3","is_derivative":false,"issuer_cik":"0001225480","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001225480","owner_cik":null,"owner_name":"Tansey Casey M; Presidio Management Group X LLC; US VENTURE PARTNERS X LP; USVP X AFFILIATES LP; ROOT JONATHAN D","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":437.0,"shares_display":"437","price_per_share":1.734,"price_display":"1.73","price_state":"stated","total_value":757.758,"total_display":"757.76","shares_owned_after":136507.0,"shares_owned_after_display":"136,507","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-18","filed_date":"2022-05-19","scope":"insider"},{"id":6208203,"accession":"0001062993-22-013050","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-22-013050","line_url":"/filing/0001062993-22-013050#line-2","is_derivative":false,"issuer_cik":"0001225480","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001225480","owner_cik":null,"owner_name":"Tansey Casey M; Presidio Management Group X LLC; US VENTURE PARTNERS X LP; USVP X AFFILIATES LP; ROOT JONATHAN D","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11402.0,"shares_display":"11,402","price_per_share":1.749,"price_display":"1.75","price_state":"stated","total_value":19942.098,"total_display":"19,942.10","shares_owned_after":4280691.0,"shares_owned_after_display":"4,280,691","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-17","filed_date":"2022-05-19","scope":"insider"},{"id":6208200,"accession":"0001062993-22-013050","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-22-013050","line_url":"/filing/0001062993-22-013050#line-1","is_derivative":false,"issuer_cik":"0001225480","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001225480","owner_cik":null,"owner_name":"Tansey Casey M; Presidio Management Group X LLC; US VENTURE PARTNERS X LP; USVP X AFFILIATES LP; ROOT JONATHAN D","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":365.0,"shares_display":"365","price_per_share":1.75,"price_display":"1.75","price_state":"stated","total_value":638.75,"total_display":"638.75","shares_owned_after":136944.0,"shares_owned_after_display":"136,944","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-17","filed_date":"2022-05-19","scope":"insider"},{"id":6695414,"accession":"0001062993-22-012659","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001062993-22-012659","line_url":"/filing/0001062993-22-012659#line-6","is_derivative":false,"issuer_cik":"0001225480","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001225480","owner_cik":null,"owner_name":"Tansey Casey M; ROOT JONATHAN D; USVP X AFFILIATES LP; US VENTURE PARTNERS X LP; Presidio Management Group X LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12374.0,"shares_display":"12,374","price_per_share":1.746,"price_display":"1.75","price_state":"stated","total_value":21605.004,"total_display":"21,605.00","shares_owned_after":4292093.0,"shares_owned_after_display":"4,292,093","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-16","filed_date":"2022-05-16","scope":"insider"},{"id":6695412,"accession":"0001062993-22-012659","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001062993-22-012659","line_url":"/filing/0001062993-22-012659#line-5","is_derivative":false,"issuer_cik":"0001225480","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001225480","owner_cik":null,"owner_name":"Tansey Casey M; ROOT JONATHAN D; USVP X AFFILIATES LP; US VENTURE PARTNERS X LP; Presidio Management Group X LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":395.0,"shares_display":"395","price_per_share":1.746,"price_display":"1.75","price_state":"stated","total_value":689.67,"total_display":"689.67","shares_owned_after":137309.0,"shares_owned_after_display":"137,309","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-16","filed_date":"2022-05-16","scope":"insider"},{"id":6695410,"accession":"0001062993-22-012659","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001062993-22-012659","line_url":"/filing/0001062993-22-012659#line-4","is_derivative":false,"issuer_cik":"0001225480","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001225480","owner_cik":null,"owner_name":"Tansey Casey M; ROOT JONATHAN D; USVP X AFFILIATES LP; US VENTURE PARTNERS X LP; Presidio Management Group X LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21906.0,"shares_display":"21,906","price_per_share":1.839,"price_display":"1.84","price_state":"stated","total_value":40285.134,"total_display":"40,285.13","shares_owned_after":4304467.0,"shares_owned_after_display":"4,304,467","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-13","filed_date":"2022-05-16","scope":"insider"},{"id":6695408,"accession":"0001062993-22-012659","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001062993-22-012659","line_url":"/filing/0001062993-22-012659#line-3","is_derivative":false,"issuer_cik":"0001225480","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001225480","owner_cik":null,"owner_name":"Tansey Casey M; ROOT JONATHAN D; USVP X AFFILIATES LP; US VENTURE PARTNERS X LP; Presidio Management Group X LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":701.0,"shares_display":"701","price_per_share":1.839,"price_display":"1.84","price_state":"stated","total_value":1289.139,"total_display":"1,289.14","shares_owned_after":137704.0,"shares_owned_after_display":"137,704","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-13","filed_date":"2022-05-16","scope":"insider"},{"id":6695406,"accession":"0001062993-22-012659","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-22-012659","line_url":"/filing/0001062993-22-012659#line-2","is_derivative":false,"issuer_cik":"0001225480","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001225480","owner_cik":null,"owner_name":"Tansey Casey M; ROOT JONATHAN D; USVP X AFFILIATES LP; US VENTURE PARTNERS X LP; Presidio Management Group X LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10464.0,"shares_display":"10,464","price_per_share":2.003,"price_display":"2.00","price_state":"stated","total_value":20959.392,"total_display":"20,959.39","shares_owned_after":4326373.0,"shares_owned_after_display":"4,326,373","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-12","filed_date":"2022-05-16","scope":"insider"},{"id":6695404,"accession":"0001062993-22-012659","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-22-012659","line_url":"/filing/0001062993-22-012659#line-1","is_derivative":false,"issuer_cik":"0001225480","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001225480","owner_cik":null,"owner_name":"Tansey Casey M; ROOT JONATHAN D; USVP X AFFILIATES LP; US VENTURE PARTNERS X LP; Presidio Management Group X LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":336.0,"shares_display":"336","price_per_share":2.003,"price_display":"2.00","price_state":"stated","total_value":673.008,"total_display":"673.01","shares_owned_after":138405.0,"shares_owned_after_display":"138,405","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-12","filed_date":"2022-05-16","scope":"insider"},{"id":6239498,"accession":"0001062993-22-012169","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001062993-22-012169","line_url":"/filing/0001062993-22-012169#line-6","is_derivative":false,"issuer_cik":"0001225480","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001225480","owner_cik":null,"owner_name":"Tansey Casey M; ROOT JONATHAN D; USVP X AFFILIATES LP; US VENTURE PARTNERS X LP; Presidio Management Group X LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4845.0,"shares_display":"4,845","price_per_share":2.345,"price_display":"2.34","price_state":"stated","total_value":11361.525,"total_display":"11,361.52","shares_owned_after":4336837.0,"shares_owned_after_display":"4,336,837","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-11","filed_date":"2022-05-11","scope":"insider"},{"id":6239492,"accession":"0001062993-22-012169","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001062993-22-012169","line_url":"/filing/0001062993-22-012169#line-5","is_derivative":false,"issuer_cik":"0001225480","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001225480","owner_cik":null,"owner_name":"Tansey Casey M; ROOT JONATHAN D; USVP X AFFILIATES LP; US VENTURE PARTNERS X LP; Presidio Management Group X LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":155.0,"shares_display":"155","price_per_share":2.346,"price_display":"2.35","price_state":"stated","total_value":363.63,"total_display":"363.63","shares_owned_after":138741.0,"shares_owned_after_display":"138,741","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-11","filed_date":"2022-05-11","scope":"insider"},{"id":6239488,"accession":"0001062993-22-012169","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001062993-22-012169","line_url":"/filing/0001062993-22-012169#line-4","is_derivative":false,"issuer_cik":"0001225480","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001225480","owner_cik":null,"owner_name":"Tansey Casey M; ROOT JONATHAN D; USVP X AFFILIATES LP; US VENTURE PARTNERS X LP; Presidio Management Group X LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":38743.0,"shares_display":"38,743","price_per_share":2.413,"price_display":"2.41","price_state":"stated","total_value":93486.859,"total_display":"93,486.86","shares_owned_after":4341682.0,"shares_owned_after_display":"4,341,682","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-10","filed_date":"2022-05-11","scope":"insider"},{"id":6239485,"accession":"0001062993-22-012169","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001062993-22-012169","line_url":"/filing/0001062993-22-012169#line-3","is_derivative":false,"issuer_cik":"0001225480","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001225480","owner_cik":null,"owner_name":"Tansey Casey M; ROOT JONATHAN D; USVP X AFFILIATES LP; US VENTURE PARTNERS X LP; Presidio Management Group X LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1241.0,"shares_display":"1,241","price_per_share":2.413,"price_display":"2.41","price_state":"stated","total_value":2994.533,"total_display":"2,994.53","shares_owned_after":138896.0,"shares_owned_after_display":"138,896","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-10","filed_date":"2022-05-11","scope":"insider"},{"id":6239482,"accession":"0001062993-22-012169","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-22-012169","line_url":"/filing/0001062993-22-012169#line-2","is_derivative":false,"issuer_cik":"0001225480","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001225480","owner_cik":null,"owner_name":"Tansey Casey M; ROOT JONATHAN D; USVP X AFFILIATES LP; US VENTURE PARTNERS X LP; Presidio Management Group X LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3876.0,"shares_display":"3,876","price_per_share":2.536,"price_display":"2.54","price_state":"stated","total_value":9829.536,"total_display":"9,829.54","shares_owned_after":4380425.0,"shares_owned_after_display":"4,380,425","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-09","filed_date":"2022-05-11","scope":"insider"},{"id":6239476,"accession":"0001062993-22-012169","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-22-012169","line_url":"/filing/0001062993-22-012169#line-1","is_derivative":false,"issuer_cik":"0001225480","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001225480","owner_cik":null,"owner_name":"Tansey Casey M; ROOT JONATHAN D; USVP X AFFILIATES LP; US VENTURE PARTNERS X LP; Presidio Management Group X LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":124.0,"shares_display":"124","price_per_share":2.537,"price_display":"2.54","price_state":"stated","total_value":314.588,"total_display":"314.59","shares_owned_after":140137.0,"shares_owned_after_display":"140,137","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-09","filed_date":"2022-05-11","scope":"insider"},{"id":4766476,"accession":"0001062993-21-012276","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-21-012276","line_url":"/filing/0001062993-21-012276#line-2","is_derivative":false,"issuer_cik":"0001440514","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001440514","owner_cik":null,"owner_name":"Presidio Management Group X LLC; Tansey Casey M; USVP X AFFILIATES LP; US VENTURE PARTNERS X LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7861.0,"shares_display":"7,861","price_per_share":5.68,"price_display":"5.68","price_state":"stated","total_value":44650.48,"total_display":"44,650.48","shares_owned_after":4384301.0,"shares_owned_after_display":"4,384,301","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-02","filed_date":"2021-12-06","scope":"insider"},{"id":4766470,"accession":"0001062993-21-012276","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-21-012276","line_url":"/filing/0001062993-21-012276#line-1","is_derivative":false,"issuer_cik":"0001440514","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001440514","owner_cik":null,"owner_name":"Presidio Management Group X LLC; Tansey Casey M; USVP X AFFILIATES LP; US VENTURE PARTNERS X LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":252.0,"shares_display":"252","price_per_share":5.68,"price_display":"5.68","price_state":"stated","total_value":1431.36,"total_display":"1,431.36","shares_owned_after":140261.0,"shares_owned_after_display":"140,261","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-02","filed_date":"2021-12-06","scope":"insider"},{"id":4986350,"accession":"0001062993-21-011920","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001062993-21-011920","line_url":"/filing/0001062993-21-011920#line-6","is_derivative":false,"issuer_cik":"0001440514","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001440514","owner_cik":null,"owner_name":"US VENTURE PARTNERS X LP; Tansey Casey M; USVP X AFFILIATES LP; Presidio Management Group X LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18648.0,"shares_display":"18,648","price_per_share":6.437,"price_display":"6.44","price_state":"stated","total_value":120037.176,"total_display":"120,037.18","shares_owned_after":4392162.0,"shares_owned_after_display":"4,392,162","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-01","filed_date":"2021-12-01","scope":"insider"},{"id":4986347,"accession":"0001062993-21-011920","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001062993-21-011920","line_url":"/filing/0001062993-21-011920#line-5","is_derivative":false,"issuer_cik":"0001440514","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001440514","owner_cik":null,"owner_name":"US VENTURE PARTNERS X LP; Tansey Casey M; USVP X AFFILIATES LP; Presidio Management Group X LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":597.0,"shares_display":"597","price_per_share":6.437,"price_display":"6.44","price_state":"stated","total_value":3842.889,"total_display":"3,842.89","shares_owned_after":140513.0,"shares_owned_after_display":"140,513","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-01","filed_date":"2021-12-01","scope":"insider"},{"id":4986343,"accession":"0001062993-21-011920","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001062993-21-011920","line_url":"/filing/0001062993-21-011920#line-4","is_derivative":false,"issuer_cik":"0001440514","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001440514","owner_cik":null,"owner_name":"US VENTURE PARTNERS X LP; Tansey Casey M; USVP X AFFILIATES LP; Presidio Management Group X LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26559.0,"shares_display":"26,559","price_per_share":6.532,"price_display":"6.53","price_state":"stated","total_value":173483.388,"total_display":"173,483.39","shares_owned_after":4410810.0,"shares_owned_after_display":"4,410,810","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-11-30","filed_date":"2021-12-01","scope":"insider"},{"id":4986340,"accession":"0001062993-21-011920","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001062993-21-011920","line_url":"/filing/0001062993-21-011920#line-3","is_derivative":false,"issuer_cik":"0001440514","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001440514","owner_cik":null,"owner_name":"US VENTURE PARTNERS X LP; Tansey Casey M; USVP X AFFILIATES LP; Presidio Management Group X LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":850.0,"shares_display":"850","price_per_share":6.533,"price_display":"6.53","price_state":"stated","total_value":5553.05,"total_display":"5,553.05","shares_owned_after":141110.0,"shares_owned_after_display":"141,110","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-11-30","filed_date":"2021-12-01","scope":"insider"}],"next_cursor":"2021-11-30|4986340","ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001828522","name":"eFFECTOR Therapeutics, Inc.","url":"/issuer/0001828522","role":"Ten percent owner","n_filings":14,"first_seen":"2021-11-12","last_seen":"2022-08-03"},{"type":"issuer","type_label":"ISSUER","cik":"0001531048","name":"Inari Medical, Inc.","url":"/issuer/0001531048","role":"Ten percent owner","n_filings":2,"first_seen":"2020-05-27","last_seen":"2020-11-19"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001602744","retrieved_at":"2026-08-21T09:50:05+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}